ArticleInternational journal of molecular sciences2022

Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis.

José Luis Morgado-Pascual et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.